NEWS

Publication
15.09.2020
The Anti-histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits SARS-CoV-2 Infection in Reconstituted Human Nasal Tissue In Vitro.



Press Release
20.04.2020
CALYXHA announces grant of a European Patent on neurodegenerative diseases.



04.03.2020
CALYXHA endeavors to develop novel approaches to tissue degenerative diseases and receives support from Austrian VC and international investors